Kalvista Change To Netincome from 2010 to 2024

KALV Stock  USD 10.07  0.08  0.79%   
Kalvista Pharmaceuticals Change To Netincome yearly trend continues to be fairly stable with very little volatility. Change To Netincome is likely to outpace its year average in 2024. During the period from 2010 to 2024, Kalvista Pharmaceuticals Change To Netincome regression line of quarterly data had r-squared of  0.46 and coefficient of variation of  129.15. View All Fundamentals
 
Change To Netincome  
First Reported
2015-01-31
Previous Quarter
2.2 M
Current Value
2.6 M
Quarterly Volatility
1.4 M
 
Yuan Drop
 
Covid
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 424 K, Interest Expense of 0.0 or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 46.33, Dividend Yield of 0.0 or Days Sales Outstanding of 268. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Kalvista Pharmaceuticals Correlation against competitors.
For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.

Latest Kalvista Pharmaceuticals' Change To Netincome Growth Pattern

Below is the plot of the Change To Netincome of Kalvista Pharmaceuticals over the last few years. It is Kalvista Pharmaceuticals' Change To Netincome historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Change To Netincome10 Years Trend
Slightly volatile
   Change To Netincome   
       Timeline  

Kalvista Change To Netincome Regression Statistics

Arithmetic Mean3,031,387
Coefficient Of Variation129.15
Mean Deviation2,903,479
Median2,863,000
Standard Deviation3,915,150
Sample Variance15.3T
Range14.2M
R-Value0.68
Mean Square Error8.9T
R-Squared0.46
Significance0.01
Slope593,834
Total Sum of Squares214.6T

Kalvista Change To Netincome History

20243.8 M
20228.4 M
202113.2 M
20206.4 M
20194.2 M
20182.9 M
2017409 K

About Kalvista Pharmaceuticals Financial Statements

Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Change To Netincome, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change To Netincome3.4 M3.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Kalvista Stock Analysis

When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.